January 13, 2015
Otsuka Pharmaceutical and Fuso Pharmaceutical Industries will end their licensing deals with OncoTherapy regarding therapeutic peptide vaccines for cancers. OncoTherapy said on January 8 that it was notified by the two companies of the termination of the deals on the...read more